|国家科技期刊平台
首页|期刊导航|肿瘤防治研究|铁死亡相关基因GLS2在泛癌中的预后及免疫价值

铁死亡相关基因GLS2在泛癌中的预后及免疫价值OA北大核心CSTPCD

Role of Ferroptosis-related Gene GLS2 in Pan-cancer Prognosis and Immunity

中文摘要英文摘要

目的 基于生物信息学方法评估铁死亡相关基因GLS2在泛癌中对预后及免疫的相关作用.方法 采用癌症基因组图谱(TCGA)、GTEx、癌症细胞系百科全书(CCLE)及国际癌症基因组联盟(ICGC)等在线数据库进行GLS2基因泛癌分析,从基因表达、基因突变、生存分析、免疫浸润、免疫检查点相关基因和TMB及MSI等多个方面挖掘GLS2基因在不同肿瘤中的作用.结果 GLS2在大多数癌组织与癌旁组织的表达具有显著差异,并且该表达与这些癌症的预后相关.在多种癌症中,GLS2的表达与免疫细胞浸润之间存在正相关关系,并与免疫检查点相关基因有关.GLS2还与TMB、MSI和甲基化呈正相关,其表达与可能的治疗反应具有一定关系.结论 通过对铁死亡相关基因GLS2的泛癌分析表明,GLS2的表达可能作为肾透明细胞癌、肾上腺皮质癌、肺腺癌、胰腺癌诊断及预后的重要标志物.

Objective To assess the role of the ferroptosis-associated gene GLS2 in the prognosis of pan-cancer and immunity using bioinformatics methods.Methods GLS2 expression levels in pan-cancer were profiled using publicly available databases:The Cancer Genome Atlas,GTEx,Cancer Cell Line Ency-clopedia and the International Cancer Genome Consortium.The aim was to explore the role of GLS2 gene expression,gene variation survival analysis,immune infiltration,immune checkpoint related genes,TMB,and MSI in different tumors.Results Difference in GLS2 expression levels between cancer and paraneoplastic tissues was statistically significant in most cancer types,and the expression level was correlated with survi-val in these cancer types.A positive correlation was found between GLS2 expression and immune cell infiltration in multiple cancer types,and GLS2 expression level was positively correlated with TMB,MSI,and methylation,and its expression is an indicator for potential therapeutic response.Conclusion Pan-cancer analysis shows that the ferroptosis-related gene GLS2 can be used as a diagnostic and prognostic marker of clear cell carcinoma of kidney,adrenocortical carcinoma,lung adenocarcinoma,and pancreatic cancer.

潘月眉;孙之;赵倩倩;胡雪雪;王传玺

250021 济南,山东大学||250021 济南,山东省立医院肿瘤放疗科250021 济南,山东第一医科大学附属省立医院医学影像科250021 济南,山东大学250021 济南,山东省立医院肿瘤放疗科||250021 济南,山东第一医科大学附属省立医院肿瘤放疗科250021 济南,山东大学||250021 济南,山东省立医院肿瘤放疗科||250021 济南,山东第一医科大学附属省立医院肿瘤放疗科

临床医学

铁死亡GLS2泛癌预后免疫

FerroptosisGLS2Pan-cancerPrognosisImmune

《肿瘤防治研究》 2024 (003)

169-177 / 9

Natural Science Foundation of China(No.82172672);Natural Science Foundation of Shandong Province(No.ZR2021MH379) 国家自然科学基金面上项目(82172672);山东省自然科学基金(ZR2021MH379)

10.3971/j.issn.1000-8578.2024.23.0986

评论